• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, Dec. 20

Actavis Group is to acquire a manufacturing plant from the Chennai-based Grandix Pharmaceuticals, for an undisclosed amount, an official release said.

The company intends to increase the manufacturing capacity of the plant to approximately 4 billion tablets over the next 18 months. Actavis has also opened a new Active Pharmaceutical Ingredient development unit for backward integration of its Indian business. The acquisition follows the Group's purchase of Lotus Laboratories based in Bangalore in February last year.

More Stories on : Mergers & Acquisitions | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Bhagyangar to sell 5.7 acres

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line